Literature DB >> 8120272

Prevalence of food allergy and intolerance in the adult Dutch population.

J J Jansen1, A F Kardinaal, G Huijbers, B J Vlieg-Boerstra, B P Martens, T Ockhuizen.   

Abstract

The prevalence of food allergy and intolerance (FA/FI) was studied in a random sample (n = 1483) of the Dutch adult population. First, the self-reported FA/FI reactions were investigated by questionnaire. Subsequently, in a clinical follow-up study, it was determined in how many cases this self-reported FA/FI could be objectively confirmed by double-blind placebo-controlled food challenge. More than 10% of the population (12.4%) reported FA/FI to specific food(s). Of the 144 subjects potentially available for the clinical follow-up study, 73 completed the whole protocol. In 12 subjects FA/FI could be confirmed by double-blind placebo-controlled food challenge. This indicates a minimum prevalence of FA/FI in the population of 0.8% (12 of 1483). Assuming that FA/FI is equal among participants, nonparticipants, and dropouts, the prevalence of FA/FI in the Dutch adult population is estimated to be 2.4%. The food (ingredients) involved included pork, white wine, and menthol. Two persons reacted to additives. In three persons glucose intolerance was observed. However, these specific intolerances probably do not reflect the distribution in the general population because the study population formed an extremely heterogeneous group, both with regard to the offending foods and the symptoms. The majority of the subjects had no serious complaints that required medical advice. We conclude that there is a gap between self-reported FA/FI and FA/FI that can be objectively confirmed by double-blind placebo-controlled food challenge.

Entities:  

Mesh:

Year:  1994        PMID: 8120272     DOI: 10.1016/0091-6749(94)90353-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  42 in total

Review 1.  GMO: human health risk assessment.

Authors:  G D'Agnolo
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

2.  Should milk-specific IgE antibodies be measured in adults in primary care?

Authors:  Sari Anthoni; Peter Elg; Tari Haahtela; Kaija-Leena Kolho
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

3.  Identification of tropomyosins as major allergens in antarctic krill and mantis shrimp and their amino acid sequence characteristics.

Authors:  Kanna Motoyama; Yota Suma; Shoichiro Ishizaki; Yuji Nagashima; Ying Lu; Hideki Ushio; Kazuo Shiomi
Journal:  Mar Biotechnol (NY)       Date:  2008-06-03       Impact factor: 3.619

4.  Subjective health complaints and modern health worries in patients with subjective food hypersensitivity.

Authors:  Ragna Lind; Gülen Arslan; Hege R Eriksen; Gudrun Kahrs; Tone Tangen Haug; Erik Florvaag; Arnold Berstad
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

Review 5.  Perceived triggers of asthma: key to symptom perception and management.

Authors:  T Janssens; T Ritz
Journal:  Clin Exp Allergy       Date:  2013-09       Impact factor: 5.018

Review 6.  Clinical spectrum of food allergies: a comprehensive review.

Authors:  Marco H-K Ho; Wilfred H-S Wong; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

7.  Peanut allergy: an overview.

Authors:  Nasser Al-Ahmed; Shirina Alsowaidi; Peter Vadas
Journal:  Allergy Asthma Clin Immunol       Date:  2008-12-15       Impact factor: 3.406

Review 8.  Peanut allergy: an overview.

Authors:  Saleh Al-Muhsen; Ann E Clarke; Rhoda S Kagan
Journal:  CMAJ       Date:  2003-05-13       Impact factor: 8.262

Review 9.  Psychological aspects of food allergy.

Authors:  Kim Kelsay
Journal:  Curr Allergy Asthma Rep       Date:  2003-01       Impact factor: 4.806

10.  Physical properties of intact proteins may predict allergenicity or lack thereof.

Authors:  Suchita Singh; Bhupesh Taneja; Sundeep Santosh Salvi; Anurag Agrawal
Journal:  PLoS One       Date:  2009-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.